Presentation TCT 2019 Moving From “Signal Detection” to “Signal Discernment”: An FDA View Presenter: Eleni Whatley September 26, 2019 REGISTER for free or LOG IN to view this content Policy & Practice Presentation TCT 2019 Up Next Presentation TCT 2019 Statistical Considerations: Competing Risk, Pooling Data, RCT vs. Observational Data Presenter: Roseann White September 26, 2019 More slides + Presentation TCT 2019 Safety of PTX Devices for PAD in Japan: Academic View Presenter: Masato Nakamura September 26, 2019 Presentation TCT 2019 Role of PCSK9 Inhibitors Post-PCI and ACS Presenter: Marc Bonaca September 26, 2019 We Recommend
Presentation TCT 2019 Statistical Considerations: Competing Risk, Pooling Data, RCT vs. Observational Data Presenter: Roseann White September 26, 2019
Presentation TCT 2019 Safety of PTX Devices for PAD in Japan: Academic View Presenter: Masato Nakamura September 26, 2019
Presentation TCT 2019 Role of PCSK9 Inhibitors Post-PCI and ACS Presenter: Marc Bonaca September 26, 2019